When patient lives are at risk, every minute counts. That’s why ANiGENT has collaborated with the Mayo Clinic to market the first comprehensive drug diversion prevention platform that utilizes machine learning technology to track all users, all drugs, in all locations
Our Solution
MAAP = Intuitive. Comprehensive. Predictive.
MAAP stands for Medication Administration & Analysis Program, and we’re proud to say that it’s one of the most comprehensive, drug diversion solution available in the market. Here’s what makes it so powerful.
• MAAP Analytics™ pulls data from multiple sources.
• It uses AI algorithms in BI technologies to segment risks by user, medication, and location.
• It segments discoveries quickly to identify either drug diversion or opportunities for practice improvements.
ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements. To learn more about ANiGENT and MAAP Analytics, visit ANiGENT.com.
This post is related to:
Drug Diversion Monitoring, Diversion Prevention
